Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03198013
What this trial is testing

Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males

Who this might be right for
Immunoscience
Bristol-Myers Squibb 120
Not applicableStudy completedNCT05642624
What this trial is testing

The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock

Who this might be right for
Fungal Infection
Southeast University, China 20
Early research (Phase 1)Study completedNCT00480818
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 80
Early research (Phase 1)Study completedNCT05184868
What this trial is testing

AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study

Who this might be right for
Diabetes Mellitus, Type 1
Arecor Limited 24
Early research (Phase 1)Study completedNCT05584111
What this trial is testing

Oral Administration of STC-15 in Subjects With Advanced Malignancies

Who this might be right for
Advanced CancerAdvanced Solid TumorCancer
STORM Therapeutics LTD 42
Early research (Phase 1)Study completedNCT02096601
What this trial is testing

A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 16
Early research (Phase 1)Study completedNCT04501744
What this trial is testing

M701 (EpCAM and CD3) in Malignant Ascites

Who this might be right for
Malignant AscitesCancer
Wuhan YZY Biopharma Co., Ltd. 35
Large-scale testing (Phase 3)Study completedNCT05001737
What this trial is testing

Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Who this might be right for
Macrophage Activation SyndromeSecondary Hemophagocytic LymphohistiocytosisStill Disease+4 more
Swedish Orphan Biovitrum 33
Testing effectiveness (Phase 2)Study completedNCT02032836
What this trial is testing

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 27
Testing effectiveness (Phase 2)Looking for participantsNCT06938867
What this trial is testing

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Who this might be right for
E Coli InfectionsAllogenic Transplant Patients
SNIPR Biome Aps. 24
Early research (Phase 1)Active Not RecruitingNCT03913949
What this trial is testing

Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaNon Hodgkin Lymphoma
Ascentage Pharma Group Inc. 74
Testing effectiveness (Phase 2)Study completedNCT05039099
What this trial is testing

Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
AL-S Pharma 73
Early research (Phase 1)WithdrawnNCT04082481
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants

Who this might be right for
Healthy Volunteers
Takeda
Early research (Phase 1)UnknownNCT04479865
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy Adults

Who this might be right for
Healthy
Dong-A ST Co., Ltd. 49
Early research (Phase 1)Study completedNCT05564611
What this trial is testing

PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult Subjects

Who this might be right for
Healthy
Kashiv BioSciences, LLC 204
Early research (Phase 1)Study completedNCT05332704
What this trial is testing

Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

Who this might be right for
Plaque Psoriasis
Ono Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Study completedNCT05351671
What this trial is testing

A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS

Who this might be right for
Healthy
ReAlta Life Sciences, Inc. 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05503264
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

Who this might be right for
NMDAR Autoimmune EncephalitisLGI1 Autoimmune Encephalitis
Hoffmann-La Roche 122
Early research (Phase 1)Study completedNCT05663593
What this trial is testing

Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Haisco Pharmaceutical Group Co., Ltd. 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581314
What this trial is testing

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Advanced Triple-Negative Breast CancerMetastatic Triple-negative Breast Cancer
Telomir Pharmaceuticals, Inc. 76
Next Page